Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 227.72 | (111.28) | (149.33)¢ | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 318.31 | (33.96) | (38.67)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
No recent information was found.
AstraZeneca is sued over asthma drug deal | 27-May-2009 | LA Times |
Local Digest | 09-May-2009 | Washington Post |
Local Digest | 08-May-2009 | Washington Post |
Currency | US Dollars |
Share Price | $ 4.26 |
Change Today | $ 0.07 |
% Change | 1.67 % |
52 Week High | $5.49 |
52 Week Low | $3.93 |
Volume | 598,658 |
Shares Issued | 52.38m |
Market Cap | $223.14m |
RiskGrade | 297 |
Strong Buy | 0 |
Buy | 2 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
Time | Volume / Share Price |
15:59 | 1,000 @ $4.27 |
15:59 | 100 @ $4.27 |
15:59 | 100 @ $4.27 |
15:59 | 400 @ $4.27 |
15:59 | 200 @ $4.27 |
You are here: research